Get started
Author

Edward Libby

Observed institution: Fred Hutch Cancer Center
OpenAlex ID: A5137395641
Daratumumab-bortezomib-cyclophosphamide-dexamethasone for newly diagnosed amyloidosis: ANDROMEDA final survival analysis
2026 · Efstathios Kastritis, Giovanni Palladini, et al. · Blood · 4
Efficacy and Safety of Anselamimab in Immunoglobulin Light Chain Amyloidosis: Results From the Randomized CARES Trials
2026 · Ashutosh D. Wechalekar, Angela Dispenzieri, et al. · Journal of Clinical Oncology · 2
Works count: 2
Citation count: 6
H-index: 2
I10-index:
Year
Topic
Type